218 related articles for article (PubMed ID: 11602046)
1. Gammadelta T cell activation by chronic HIV infection may contribute to intrahepatic vdelta1 compartmentalization and hepatitis C virus disease progression independent of highly active antiretroviral therapy.
Agrati C; D'Offizi G; Narciso P; Selva C; Pucillo LP; Ippolito G; Poccia F
AIDS Res Hum Retroviruses; 2001 Sep; 17(14):1357-63. PubMed ID: 11602046
[TBL] [Abstract][Full Text] [Related]
2. Vdelta1 T lymphocytes expressing a Th1 phenotype are the major gammadelta T cell subset infiltrating the liver of HCV-infected persons.
Agrati C; D'Offizi G; Narciso P; Abrignani S; Ippolito G; Colizzi V; Poccia F
Mol Med; 2001 Jan; 7(1):11-9. PubMed ID: 11474123
[TBL] [Abstract][Full Text] [Related]
3. Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
Kuntzen T; Tural C; Li B; Feldmann G; Kupfer B; Nischalke HD; Clotet B; Sauerbruch T; Rockstroh JK; Spengler U
AIDS; 2008 Jan; 22(2):203-10. PubMed ID: 18097222
[TBL] [Abstract][Full Text] [Related]
4. Hepatic compartmentalization of exhausted and regulatory cells in HIV/HCV-coinfected patients.
Barrett L; Trehanpati N; Poonia S; Daigh L; Sarin SK; Masur H; Kottilil S
J Viral Hepat; 2015 Mar; 22(3):281-8. PubMed ID: 25174689
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte distribution and intrahepatic compartmentalization during HCV infection: a main role for MHC-unrestricted T cells.
Agrati C; Nisii C; Oliva A; D'Offizi G; Montesano C; Pucillo LP; Poccia F
Arch Immunol Ther Exp (Warsz); 2002; 50(5):307-16. PubMed ID: 12455864
[TBL] [Abstract][Full Text] [Related]
6. Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy.
Abad-Fernández M; Moreno A; Dronda F; del Campo S; Quereda C; Casado JL; Pérez-Elías MJ; Moreno S; Vallejo A
AIDS; 2015 Feb; 29(4):401-9. PubMed ID: 25565497
[TBL] [Abstract][Full Text] [Related]
7. Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapy.
Sitia G; De Bona A; Bagaglio S; Galli L; Paties CT; Uberti-Foppa C; Guidotti LG; Lazzarin A; Morsica G
Antivir Ther; 2006; 11(3):385-9. PubMed ID: 16759056
[TBL] [Abstract][Full Text] [Related]
8. Transient liver injury associated with the early recovery of HCV-specific T-cell responses and HCV rebound in HIV-1/HCV coinfected patients undergoing highly active antiretroviral therapy.
Kang F; Chen W; Zhang X; Nie W; Fu J; Xu X; Zhao P; Zhang X; Li W; Wang FS; Zhang Z; Zhao M
J Acquir Immune Defic Syndr; 2013 Feb; 62(2):135-42. PubMed ID: 23075912
[TBL] [Abstract][Full Text] [Related]
9. Increase in Vdelta1+ gammadelta T cells in the peripheral blood and bone marrow as a selective feature of HIV-1 but not other virus infections.
Rossol R; Dobmeyer JM; Dobmeyer TS; Klein SA; Rossol S; Wesch D; Hoelzer D; Kabelitz D; Helm EB
Br J Haematol; 1998 Mar; 100(4):728-34. PubMed ID: 9531341
[TBL] [Abstract][Full Text] [Related]
10. Preservation of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses despite global loss of CD4+ T cells in HCV/HIV coinfection.
Morishima C; Shuhart MC; Yoshihara CS; Paschal DM; Silva MA; Thomassen LV; Emerson SS; Gretch DR
J Infect Dis; 2007 Aug; 196(4):577-86. PubMed ID: 17624844
[TBL] [Abstract][Full Text] [Related]
11. HIV and hepatitis C coinfection.
Matthews GV; Dore GJ
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
[TBL] [Abstract][Full Text] [Related]
12. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy.
Tedaldi EM; Baker RK; Moorman AC; Alzola CF; Furhrer J; McCabe RE; Wood KC; Holmberg SD;
Clin Infect Dis; 2003 Feb; 36(3):363-7. PubMed ID: 12539079
[TBL] [Abstract][Full Text] [Related]
13. Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV-HCV-coinfected patients under highly active antiretroviral treatment.
de Larrañaga GF; Wingeyer SD; Puga LM; Alonso BS; Benetucci JA
Eur J Clin Microbiol Infect Dis; 2006 Feb; 25(2):98-103. PubMed ID: 16477441
[TBL] [Abstract][Full Text] [Related]
14. Preservation of immune function and anti-hepatitis C virus (HCV) immune responses after liver transplantation in HIV-HCV coinfected patients (ANRS-HC08 "THEVIC" trial).
Samri A; Roque-Afonso AM; Beran O; Tateo M; Teicher E; Feray C; Sebagh M; Guettier C; Dussaix E; Vittecoq D; Samuel D; Autran B; Duclos-Vallée JC
J Hepatol; 2009 Dec; 51(6):1000-9. PubMed ID: 19833404
[TBL] [Abstract][Full Text] [Related]
15. Change in transaminases in hepatitis C virus- and HIV-coinfected patients after highly active antiretroviral therapy: differences between complete and partial virologic responders?
Gavazzi G; Bouchard O; Leclercq P; Morel-Baccard C; Bosseray A; Dutertre N; Micoud M; Morand P
AIDS Res Hum Retroviruses; 2000 Jul; 16(11):1021-3. PubMed ID: 10933615
[TBL] [Abstract][Full Text] [Related]
16. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C coinfection enhances sensitization of CD4(+) T-cells towards Fas-induced apoptosis in viraemic and HAART-controlled HIV-1-positive patients.
Körner C; Tolksdorf F; Riesner K; Krämer B; Schulte D; Nattermann J; Rockstroh JK; Spengler U
Antivir Ther; 2011; 16(7):1047-55. PubMed ID: 22024520
[TBL] [Abstract][Full Text] [Related]
18. Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients.
Woitas RP; Rockstroh JK; Beier I; Jung G; Kochan B; Matz B; Brackmann HH; Sauerbruch T; Spengler U
AIDS; 1999 Jul; 13(11):1313-22. PubMed ID: 10449283
[TBL] [Abstract][Full Text] [Related]
19. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
Rockstroh JK; Mocroft A; Soriano V; Tural C; Losso MH; Horban A; Kirk O; Phillips A; Ledergerber B; Lundgren J;
J Infect Dis; 2005 Sep; 192(6):992-1002. PubMed ID: 16107951
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal study in HIV/HCV-coinfected HAART-naive patients and role of HCV genotype.
Caudai C; Pianese M; Zacchini F; Toti M; Zazzi M; Valensin PE
J Clin Virol; 2005 Feb; 32(2):151-5. PubMed ID: 15653418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
